The effect of pancuronium on the cardiovascular system of the dog was studied in 12 greyhounds who were anaesthetized with pentobarbitone 30-40 mg/kg body weight. During the study, the animals were artificially ventilated to give an end-tidal carbon dioxide in the range 4·0-4·5 per cent. Duplicate cardiac output measurements were made before and ten minutes after the intravenous administration of pancuronium (0· 18 mg / kg). There was a slight (but statistically insignificant) fall in cardiac output. Heart rate, aortic and pulmonary arterial pressures remained substantially unaltered. It is suggested that pancuronium should be used in the dog when muscle relaxation is required during pentobarbitone anaesthesia. In this u:'ay cardiovascular changes related to the drugs themselves will be minimized.
During animal studies, it may be necessary to use muscle relaxants to ensure adequate experimental conditions for various cardiovascular and respiratory measurements. When this is so, it is important that the drugs used do not of themselves produce major cardiorespiratory changes which would invalidate the interpretation of alterations due to other factors. In 1970, Smith, Proctor and Spence reported on the cardiovascular effects of pancuronium when administered to a group of dogs during controlled ventilation with hyperbaric nitrous oxide and oxygen. They found a slight rise in mean arterial blood pressure and in cardiac output. The use of hyperbaric nitrous oxide for background anaesthesia would only be possible in a few centres and therefore it was decided to carry out a study of the effects of pancuronium in the dog during pentobarbitone anaesthesia which is widely used in physiological studies. As this study was carried out before another protocol was commenced, it was only possible to follow changes over a 15-minute period following pancuronium administration.
METHODS
Twelve greyhounds were anaesthetized with intravenous pentobarbitone in a dose of 30-40 mg/kg body weight. They were placed supine in a V-shaped trough, intubated and ventilated throughout the study with air using a Cape volume preset ventilator. To allow collection of expired gases, a pressure-operated collect valve (Sykes 1969 ) was used. Ventilation was maintained at a rate of 15 breaths per minute with the volume adjusted to produce an end-tidal carbon dioxide of 4'0-4,5 per cent (as measured bv a Hartmann-Braun URAS 4 infra-red analyser).
Arterial and venous cannulations were then performed to allow measurement of cardiac output, arterial pressure, pulse rate and pulmonary arterial pressure. Airway pressure was also recorded. Measurements were made using Consolidated Electrodynamics pressure transducers and were displayed on a Device5 4 channel hot-wire polygraph and on an oscilloscope. The transducers were calibrated repeatedly against water manometers. Cardiac output measurements were made using the dye dilution technique with indocyanine green and a Gilford densitometer.
After completion of surgical preparations and calibration of pressure channels, the animal was left undisturbed for a period of 20 minutes to ensure a stable cardiovascular state. Duplicate cardiac output measurements were made and then pancuronium bromide was injected intravenously in a dose of 0 ·18 mg/kg body weight. Vascular responses were followed Anaesthesia and Intensive Care, Vol. IV, No. 2, May, 1976 D and duplicate cardiac output measurements repeated ten minutes after pancuronium administration.
H.ESULTS
The administration of pancuronium was associated with a slight fall in mean cardiac output (Table ] ) when valuE'S before and ten minutes after drug administration were compared. The fall from 3 ·99 to 3 ·49 litres/ minute (mean values) did not reach statistical significance when evaluated by Student's t test. Similarly there were no significant changes in the mean aortic pressure or in pulse rate over the period of measurement (Table 2) . Statistical testing was by analysis of variance. Analysis of the changes in pulmonary arterial pressure just reached statistical significance at the five per cent level of probability but no clear-cut pattern of change was apparent in the mean values obtained (Table 2) . Airways pressures remained unchanged.
DrscussIOX
Of itself pentobarbitone anaesthesia in the dog causes various changes in cardioyascular function (Steiner and Calvin HJli7) . :\lost notable amongst these is the depression of vagal activity with a resultant tachycardia. Although Howell and Howarth (HI59) found that cardiac output in dogs fdl after induction of pentobarbitone anaesthesia (2;; mg/kg) the\' suggested that at one hour, relatiyely stable cardiac outputs could be anticipated. Within the 15-minute duration of the present study, marked change was very unlikely to be related to pentobarbitone alone.
In the present stud v the tachycardia was present but heart rate and vascular pressures had been stable for approximately 20 minutes at the time of pancuronium administration. It therefore seemed reasonable to attribute any cardiovascular changes at the time of administration of pancuronium to its direct or indirect effects. Smith et al. (HI70) reported a slight rise in cardiac output in association with the administration of pancuronium in a dose of 0'176 mg/kg during hyperbaric nitrous oxide and oxygen anaesthesia. They also noted a slight increase in heart rate and in mean arterial blood pressure. In the present study, a similar dose of pancuronium produced a slight fall in cardiac output but virtually no change in mean arterial pressure or heart rate as measured at a similar time (10 minutes) after pancuronium administration. By contrast, Smith et al. (1970) reported a fall in cardiac output, blood pressure and heart rate when tubocurarine was admini"tcred. 1 \/,illdIlCf' r;tll0 = 2 33 F =-375 P 11', 7 V,lIldfln' rdllo = 385 F = 375 P <'0 05
3 VarlOHH f' r<l\IO cc 1 62 F = 375 P"-11 ~ Chloralose anaesthesia lI<IS also been used in animal studies when it is necessary to preserve the integrity of the cardio\'ascular s\'stem. However in previous studies in this department (Loh, Seed and Sykes HI7; 3) it had been necessary to supplement chloralose anaesthesia with nitrous oxide and halothane during surgical preparations. As these supplements may affect cardiovascular and respiratory reflexes, it was considered that pentobarbitone was more appropriate to the experimental situation under investigation.
, '/lIa{'s/hl'sia alld III/o/siN Call', 1', , 1./1', Xo, :!, .Hal', Ifl, l;  Although pancuronium itself may have a blocking action on cardiac muscarinic receptors (Saxena and Bonta 1970) , this would tend to minimize changes in cardiac activity resulting from parasympathetic influences. The actions of pancuronium were minimal when compared with those of tubocurarine (Buckett, Marjoribanks, Marwick and Morton 1968). Thus, pancuronium is the muscle relaxant of choice for use during pentobarbitone anaesthesia in the dog when it is necessary to minimize further alterations in cardiovascular function related to these drugs.
